Is Zosano Pharma (ZSAN) Right Penny Stock to Buy in February?

Zosano Pharma (NASDAQ: ZSAN) is retreating by 33% today in premarket after taking a hit on Friday by 3.49% to $0.2159 value on a volume of 9,235,645 shares. 13 days ago Zosano offered $15.4 million worth of common stock ($0.30 per share) and warrants ($0.30 per share). Consequently, the stock declined to $0.2337 from $0.4726 on February 9.Pharma Intelligence | Informa If Zosano beats expected earnings or announces positive data of clinical trials ZSAN may rocket even 500% in a day. Its penny price attracts many gamblers and short squeeze-oriented buyers today. Watching the stock is highly recommended now. At the time of writing, it is trading at $0.1450 per share being a top loser in the premarket.